BDX and IIQ are making incredibly similar claims in terms of specificity, sensitivity, accuracy
Both are blood tests - but operate around different molecules
BDX currently focused on breast cancer only - but hinting at other tests
IIQ looks like its 1 year ahead in terms of launch a lab test - IIQ Dec '23 / BDX Dec '24
BDX MC = $24.3 mill
IIQ MC = $57 mill
Anybody got a view on how to compare them? Who has the better chance to succeed?
BDX v IIQ
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
0.015(3.09%) |
Mkt cap ! $55.76M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 50.0¢ | 47.5¢ | $47.43K | 97.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 107495 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 7361 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |